from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0473/-

LFCtreatmentdescriptionclass of inhibitor

-0.413

Amikacinug/mL Amikacintranslation

-0.354

Cap5-10ug/mL Capreomycintranslation

-0.926

Rox10-50 ug/mL Roxithromycintranslation

-0.182

SM2-5 ug/mL Streptomycintranslation

-0.767

Tet5-10 ug/mL Tetracyclinetranslation

-1.278

Rif0.2-5ug/mL Rifampicintranscription

-0.703

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.858

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.839

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.481

CPZ10-50 ug/mL Chlorpromazinerespiration

1.355

Clofazimine10-13 ug/mL Clofaziminerespiration

0.081

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.812

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.608

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.069

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.350

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.371

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.057

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.084

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.362

KCN5-20 ug/mL Potassium cyaniderespiration

-1.909

NaN30.2-2 mM Sodium aziderespiration

0.265

Nigericin50 uM Nigericinrespiration

0.601

TRC10-150 ug/mL Triclosanrespiration

0.996

TRZ10-25 ug/mL Thioridazinerespiration

0.207

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.643

menadione6-10 ug/mL Menadionerespiration

0.463

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.245

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.383

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.857

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.117

NRP_1Non-replicating persistence stage 1dosRassociated

-0.276

Amp0.2mg/mL AmpicillincellWall

0.071

Cephalexin20-100 ug/mL CephalexincellWall

-0.058

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.340

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.565

EMB10-20 ug/mL EthambutolcellWall

-0.140

Eta12-40 ug/mL EthionamidecellWall

-0.136

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.144

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.768

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.075

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.042

BZA0.12 mg/mL BenzamidearomaticAmides

-0.175

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.055

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.298

H2O24 mM hydrogen peroxideDNAdamaging

-0.235

Levo10 ug/mL LevofloxacinDNAdamaging

-0.711

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.921

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.218

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.518

UVUV-irradiationDNAdamaging

0.827

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.336

Antimycin12.5-50 ug/mL Antimycin A?

-0.307

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.153

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.170

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.805

PA8240.2-2 ug/mL PA-824?

1.632

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.188

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.312

Verapamil50 uM Verapamil?

-0.286

mercaptoethanol2 mM 2-Mercaptoethanol?

0.175

methoxatin10-20 ug/mL Methoxatin?